Working as a Senior Principal Business Analyst

Together, we change healthcare worldwide. At Medtronic, we push the limits of what healthcare technology and solutions can do to help alleviate pain, restore health and extend life. We challenge ourselves and each other to make tomorrow better than yesterday. It is what makes this an exciting and rewarding place to be. We can accelerate and advance our ability to create meaningful innovations - but we will only succeed with the right people on our team. Let’s work together to address universal healthcare needs and improve patients’ lives. Help us shape the future.

Since 1990, innovation has been at the heart of everything we do at Manhattan Associates. We live for it. Feed off of it. Obsess over it. Innovation fuels the supply chain and omnichannel commerce technology we make that helps power the world’s best companies. It gives them competitive advantages and growth opportunities. And it has built our reputation with customers, analysts and competitors alike. Because innovation is a never-ending process, we constantly invest in our pursuit. We’ve put nearly $600 million into research and development since 2009, $88 million in 2019 alone. And 90% of our workforce is directly focused on delivering customer value. We’re committed to developing new, powerful ways to leverage emerging technologies like cloud, artificial intelligence and machine learning. So change and disruption are met with speed, agility and flexibility. Great minds. The most-powerful tools. A single vision: to be the nucleus of innovation transforming consumer experiences. At Manhattan Associates, that’s who we are and that’s what we do. Virtually anywhere in the world and everywhere you look, you can see Manhattan’s solutions in action. Our technology connects two billion people to 20 billion consumer choices. It moves 150,000 pairs of shoes every hour. 300,000 tons of food every day. And $101 billion in retail pharmaceuticals to help people stay healthy. Over 8 million miles across four oceans and six continents, we enable, enhance and expand commerce across the globe.

Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good. As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of around $21.3 billion (19 billion euros). Our significant investment of over $3.9 billion (3.5 billion euros) in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life. We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come. Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and is part of the Boehringer Ingelheim group of companies. In addition, there are Boehringer Ingelheim Animal Health in Duluth, GA and Boehringer Ingelheim Fremont, Inc. in Fremont, CA. Boehringer Ingelheim is committed to improving lives and strengthening our communities. Please visit www.boehringer-ingelheim.us/csr to learn more about Corporate Social Responsibility initiatives. For more information, please visit www.boehringer-ingelheim.us.

CA Technologies has been acquired by Broadcom. For more information on careers please go to: www.broadcom.com